Literature DB >> 20148862

Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence.

Danielle M Novick1, Holly A Swartz, Ellen Frank.   

Abstract

OBJECTIVE: The prevalence of suicide attempts (SA) in bipolar II disorder (BPII), particularly in comparison to the prevalence in bipolar I disorder (BPI), is an understudied and controversial issue with mixed results. To date, there has been no comprehensive review of the published prevalence data for attempted suicide in BPII.
METHODS: We conducted a literature review and meta-analysis of published reports that specified the proportion of individuals with BPII in their presentation of SA data. Systematic searching yielded 24 reports providing rates of SA in BPII and 21 reports including rates of SA in both BPI and BPII. We estimated the prevalence of SA in BPII by combining data across reports of similar designs. To compare rates of SA in BPII and BPI, we calculated a pooled odds ratio (OR) and 95% confidence interval (CI) with random-effect meta-analytic techniques with retrospective data from 15 reports that detailed rates of SA in both BPI and BPII.
RESULTS: Among the 24 reports with any BPII data, 32.4% (356/1099) of individuals retrospectively reported a lifetime history of SA, 19.8% (93/469) prospectively reported attempted suicide, and 20.5% (55/268) of index attempters were diagnosed with BPII. In 15 retrospective studies suitable for meta-analysis, the prevalence of attempted suicide in BPII and BPI was not significantly different: 32.4% and 36.3%, respectively (OR = 1.21, 95% CI: 0.98-1.48, p = 0.07).
CONCLUSION: The contribution of BPII to suicidal behavior is considerable. Our findings suggest that there is no significant effect of bipolar subtype on rate of SA. Our findings are particularly alarming in concert with other evidence, including (i) the well-documented predictive role of SA for completed suicide and (ii) the evidence suggesting that individuals with BPII use significantly more violent and lethal methods than do individuals with BPI. To reduce suicide-related morbidity and mortality, routine clinical care for BPII must include ongoing risk assessment and interventions targeted at risk factors.

Entities:  

Mesh:

Year:  2010        PMID: 20148862      PMCID: PMC4536929          DOI: 10.1111/j.1399-5618.2009.00786.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  54 in total

1.  Targeting suicide prevention to modifiable risk factors: has bipolar II been overlooked?

Authors:  Hagop Akiskal
Journal:  Acta Psychiatr Scand       Date:  2007-12       Impact factor: 6.392

2.  Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study.

Authors:  Lewis L Judd; Hagop S Akiskal; Pamela J Schettler; Jean Endicott; Andrew C Leon; David A Solomon; William Coryell; Jack D Maser; Martin B Keller
Journal:  Arch Gen Psychiatry       Date:  2005-12

Review 3.  Bipolar II disorder and suicidal behavior.

Authors:  Z Rihmer; P Pestality
Journal:  Psychiatr Clin North Am       Date:  1999-09

4.  The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention.

Authors:  Judit Balázs; Franco Benazzi; Zoltán Rihmer; Annamária Rihmer; K K Akiskal; H S Akiskal
Journal:  J Affect Disord       Date:  2006-02-03       Impact factor: 4.839

5.  Suicidal risks among 2826 Sardinian major affective disorder patients.

Authors:  L Tondo; B Lepri; R J Baldessarini
Journal:  Acta Psychiatr Scand       Date:  2007-12       Impact factor: 6.392

6.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06

7.  Recurrence of bipolar disorders and major depression. A life-long perspective.

Authors:  Jules Angst; Alex Gamma; Robert Sellaro; Philip W Lavori; Heping Zhang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2003-10       Impact factor: 5.270

8.  The emerging epidemiology of hypomania and bipolar II disorder.

Authors:  J Angst
Journal:  J Affect Disord       Date:  1998-09       Impact factor: 4.839

9.  Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network.

Authors:  Gabriele S Leverich; Lori L Altshuler; Mark A Frye; Trisha Suppes; Paul E Keck; Susan L McElroy; Kirk D Denicoff; Gabriela Obrocea; Willem A Nolen; Ralph Kupka; Jörg Walden; Heinz Grunze; Sara Perez; David A Luckenbaugh; Robert M Post
Journal:  J Clin Psychiatry       Date:  2003-05       Impact factor: 4.384

10.  Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II).

Authors:  Hagop S Akiskal; Elie-Georges Hantouche; Jean-François Allilaire; Daniel Sechter; Marc L Bourgeois; Jean-Michel Azorin; Liliane Chatenêt-Duchêne; Sylvie Lancrenon
Journal:  J Affect Disord       Date:  2003-01       Impact factor: 4.839

View more
  74 in total

Review 1.  Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.

Authors:  Jordy van Enkhuizen; Mark A Geyer; Arpi Minassian; William Perry; Brook L Henry; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-08-19       Impact factor: 8.989

Review 2.  [Pharmaceutical treatment of bipolar depression. Evidence from clinical guidelines and treatment recommendations].

Authors:  S Köhler; M Bauer; T Bschor
Journal:  Nervenarzt       Date:  2014-09       Impact factor: 1.214

3.  Structural-functional decoupling predicts suicide attempts in bipolar disorder patients with a current major depressive episode.

Authors:  Haiteng Jiang; Rongxin Zhu; Shui Tian; Huan Wang; Zhilu Chen; Xinyi Wang; Junneng Shao; Jiaolong Qin; Jiabo Shi; Haiyan Liu; Yu Chen; Zhijian Yao; Qing Lu
Journal:  Neuropsychopharmacology       Date:  2020-06-30       Impact factor: 7.853

4.  Dietary intake and plasma metabolomic analysis of polyunsaturated fatty acids in bipolar subjects reveal dysregulation of linoleic acid metabolism.

Authors:  Simon J Evans; Rachel N Ringrose; Gloria J Harrington; Peter Mancuso; Charles F Burant; Melvin G McInnis
Journal:  J Psychiatr Res       Date:  2014-06-12       Impact factor: 4.791

5.  A randomized pilot study of psychotherapy and quetiapine for the acute treatment of bipolar II depression.

Authors:  Holly A Swartz; Ellen Frank; Yu Cheng
Journal:  Bipolar Disord       Date:  2012-03       Impact factor: 6.744

Review 6.  Investigating the mechanism(s) underlying switching between states in bipolar disorder.

Authors:  Jared W Young; Davide Dulcis
Journal:  Eur J Pharmacol       Date:  2015-03-23       Impact factor: 4.432

7.  In major affective disorders, early life trauma predict increased nitro-oxidative stress, lipid peroxidation and protein oxidation and recurrence of major affective disorders, suicidal behaviors and a lowered quality of life.

Authors:  Juliana Brum Moraes; Michael Maes; Chutima Roomruangwong; Kamila Landucci Bonifacio; Decio Sabbatini Barbosa; Heber Odebrecht Vargas; George Anderson; Marta Kubera; Andre F Carvalho; Sandra Odebrecht Vargas Nunes
Journal:  Metab Brain Dis       Date:  2018-03-14       Impact factor: 3.584

8.  Do Sleep Disturbances Predict or Moderate the Response to Psychotherapy in Bipolar Disorder?

Authors:  Louisa G Sylvia; Stephanie Salcedo; Amy T Peters; Pedro Vieira da Silva Magalhães; Ellen Frank; David J Miklowitz; Michael W Otto; Michael Berk; Andrew A Nierenberg; Thilo Deckersbach
Journal:  J Nerv Ment Dis       Date:  2017-03       Impact factor: 2.254

9.  Psychotherapy for Bipolar II Disorder: The Role of Interpersonal and Social Rhythm Therapy.

Authors:  Holly A Swartz; Jessica C Levenson; Ellen Frank
Journal:  Prof Psychol Res Pr       Date:  2012-04

10.  Evidence of altered DNA integrity in the brain regions of suicidal victims of Bipolar Depression.

Authors:  Mohammed S Mustak; Muralidhar L Hegde; Athira Dinesh; Gabrielle B Britton; Ruben Berrocal; K Subba Rao; N M Shamasundar; K S J Rao; T S Sathyanarayana Rao
Journal:  Indian J Psychiatry       Date:  2010-07       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.